Process for the production of 3-oxo-pregn-4-ene-21,17-carbolactones by the metal-free oxidation of 17-(3-hydroxypropyl)-3,17-dihydroxyan drostanes

Details for Australian Patent Application No. 2012202868 (hide)

Owner Bayer Pharma Aktiengesellschaft

Inventors Seba, Hartmut; Seilz, Carsten

Agent Davies Collison Cave

Pub. Number AU-A-2012202868

Parent 2006271885

Filing date 16 May 2012

Wipo publication date 7 June 2012

International Classifications

C07J 53/00 (2006.01) Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by condensation with carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms

Event Publications

31 May 2012 Complete Application Filed

7 June 2012 Application Open to Public Inspection

  Published as AU-A-2012202868

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202869-Safety Barrier for Access Opening

2012202867-Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same